WHO

    • China rebuffs WHO plan for further investigation on Covid origins

      China rebuffs WHO plan for further investigation on Covid origins

      China on Thursday said a WHO proposal to audit Chinese labs as part of further investigation into the origins of the coronavirus pandemic showed "disrespect" and "arrogance towards science", news wires reported. Last week, the World Health Organization said a second stage of the international probe should include audits of Chinese labs, amid increasing pressure from the United States for an investigation into a biotech lab in Wuhan.

      65
    • WHO proposes new Covid mission to China

      WHO proposes new Covid mission to China

      The World Health Organisation (WHO) has proposed a second phase of studies in China into the origins of the coronavirus, including audits of laboratories in Wuhan, but there is no sign yet that Beijing would accept a further international probe, diplomats said cited by Reuters.

      56
    • WHO to create first ever technology transfer hub for Covid vaccines

      WHO to create first ever technology transfer hub for Covid vaccines

      The World Health Organization is in talks to create the first-ever technology transfer hub for coronavirus vaccines in South Africa, seeking to boost supply to the continent that’s desperately in need of Covid-19 shots, Tedros Adhanom Ghebreysus, the head of the UN agency announced. The new consortium will include drugmakers Biovac and Afrigen Biologics and Vaccines, a network of universities and the Africa Centres for Disease Control and Prevention. They will develop training facilities for other vaccine makers to make shots that use a genetic code of the spike protein, known as mRNA vaccines, AP reported.

      80
    • WHO: Pandemic to be 'far more deadly' this year

      WHO: Pandemic to be 'far more deadly' this year

      The World Health Organization issued a grim warning on Friday that the second year of Covid-19 was set to be "far more deadly", as Japan extended a state of emergency amid growing calls for the Olympics to be scrapped, AFP reported. "We're on track for the second year of this pandemic to be far more deadly than the first," WHO director-general Tedros Adhanom Ghebreyesus said.

      90
    • WHO: Indian Covid-19 variant already found in 44 countries

      WHO: Indian Covid-19 variant already found in 44 countries

      The World Health Organization said on Wednesday that a variant of Covid-19 behind the acceleration of India's explosive outbreak has been found in dozens of countries all over the world, AFP reported. The B.1.617 variant of Covid-19, first found in India in October, had been detected in more than 4,500 samples uploaded to an open-access database from 44 countries in all six WHO regions.

      72
    • WHO approves the Sinopharm Covid-19 vaccine

      WHO approves the Sinopharm Covid-19 vaccine

      World Health Organization (WHO) approved for emergency usage a Covid-19 vaccine from China's state-owned pharmaceutical company Sinopharm, Reuters reported. The vaccine is the first not developed by a western country that wins the backing from WHO. The approval paves the way for China to play a more significant role in the global fight against pandemic. So far the Sinopharm vaccine has been administered to millions of people, mainly in China. It is the first time the WHO has given emergency use approval to a Chinese vaccine for any infectious disease.

      105
    • Covid-19 vaccine makers slump on expected patent waiver

      Covid-19 vaccine makers slump on expected patent waiver

      The stocks of all companies involved in production of Covid-19 vaccines fell, as US and EU backed the call from the World Health Organisation to waive patent rights claims over the jabs production, Reuters reported. The share slumps came even as some analysts raised doubts about any near-term pressure on Covid-19 vaccine sales from discussions of waiving intellectual property rights, given the manufacturing complexity and scarcity of raw materials. Combined, Pfizer and Moderna have forecast a total of over $45 billion in sales this year for their Covid-19 vaccines.

      133